Hepatitis C seroprevalence and risk behaviors in patients attending sexually transmitted disease clinics

Sexually Transmitted Diseases

Volumn 30, Issue 1, 2003, Pages 33-38

  Romanowski, Barbara ^a,c   Preiksaitis, Jutta ^b   Campbell, Patricia ^a   Fenton, Jayne ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; HEPATITIS C; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEROPREVALENCE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; VIRUS HEPATITIS;

ADOLESCENT; ADULT; AGED; ALBERTA; AMBULATORY CARE FACILITIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; RISK-TAKING; SEROEPIDEMIOLOGIC STUDIES; SUBSTANCE ABUSE, INTRAVENOUS; URBAN HEALTH;

EID: 0037230086     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200301000-00008     Document Type: Article

References (28)

1. Iwarson S, Norkrans G, Wejstal R. Hepatitis C: natural history of a unique infection. Clin Infect Dis 1995; 20:1361-1370.
2. Sharara AI, Hunt CM, Hamilton JD. Hepatitis C. Ann Intern Med 1996; 125:658-668.
3. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. N Engl J Med 1999; 340:1228-1233.
4. Seeff LB, Miller RN, Rabkin CS, et al. 45-Year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med 2000; 132:105-111.
5. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 thorough 1994. N Engl J Med 1999; 341:556-562.
6. Murphy EL, Bryzman SM, Glynn SA, et al. Risk factors for hepatitis C virus infection in United States blood donors. Hepatology 2000; 31:756-762.
7. Kao JH, Chen PJ, Yang PM, et al. Intrafamilial transmission of hepatitis C virus: the important role of infection between spouses. J Infect Dis 1992; 166:900-903.
8. Akahane Y, Aikawa T, Sugai Y, Tsuda F, Okamato H, Mishiro S. Transmission of HCV between spouses. Lancet 1992; 339:1059-1060.
9. Weinstock HS, Bolan G, Reingold AL, Polish LB. Hepatitis C virus among patients attending a clinic for sexually transmitted diseases. JAMA 1993; 269:392-394.
10. Thorpe LE, Ouellet LJ, Levy JR, Williams IT, Monterroso ER. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young drug users in Chicago, 1997-1999. J Infect Dis 2000; 182:1588-1594.
11. Lavanchy D, Gavinio P. Hepatitis C. Can J Gastroenterol 2000; 14(suppl B):67B-76B.
12. Hershow RC, Kalish LA, Sha B, Till M, Cohen M. Hepatitis C virus infection in Chicago women with or at risk for HIV infection. Sex Transm Dis 1998; 25:527-532.
13. Feldman JG, Minkoff H, Landesman S, Dehovitz J. Heterosexual transmission of hepatitis C, hepatitis B, and HIV-1 in a sample of inner-city women. Sex Transm Infect 2000; 27:338-342.
14. Munoz-Perez MA, Rodriguez-Pichardo A, Camacho F, Colmenero MA. Hepatitis C virus infection in a cohort of 1161 HIV-infected patients. Int J STD AIDS 1999; 10:69-70.
15. Giuliani M, Caprilli F, Gentili G, et al. Incidence and determinants of hepatitis C virus infection among individuals at risk of sexually transmitted diseases attending a human immunodeficiency virus Type 1 testing program. Sex Transm Dis 1997; 24:533-537.
16. Romanowski B, Campbell PJ, Preiksaitis JK, Fonseca K. Human immunodeficiency virus seroprevalence and risk behaviors in patients attending sexually transmitted disease clinics in Alberta. Sex Transm Dis 1997; 24:487-494.
17. Preiksaitis JK, Fenton J, Romanowski B. Evaluation of serum pooling for use in an anti-HCV seroprevalence study [abstract B6]. Presented at the 64th Conjoint Meeting on Infectious Diseases, Canadian Association for Clinical Microbiology and Infectious Diseases. Hamilton, Ontario, November 1996.
18. Prasad E, LeBlanc B, Chow A, Vickers R, Preiksaitis JK. Comparison of three hepatitis C enzyme immunoassay systems to develop a cost-effective algorithm for hepatitis C screening [abstract V26]. Presented at the 96th General Meeting of the American Society for Microbiology. New Orleans, May 1996.
19. Thomas DL, Cannon RO, Shapiro CN, Hook EW 3rd, Alter MJ, Quinn TC. Hepatitis C, hepatitis B, human immunodeficiency virus infections among non-intravenous drug using patients attending clinics for sexually transmitted diseases. J Infect Dis 1994; 169:990-995.
20. Goldberg D, Cameron S, Sharp G, et al. Hepatitis C virus among genitourinary clinic attenders in Scotland: unlinked anonymous testing. Int J STD AIDS 2001; 12:17-21.
21. Rooney G, Gilson RJC. Sexual transmission of hepatitis C virus infection. Sex Transm Infect 1998; 74:399-404.
22. Thomas DL, Zenilman JM, Alter HJ, et al. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore: an analysis of 309 sex partnerships. J Infect Dis 1995; 171:768-775.
23. Tedder RS, Gilson RJ, Briggs M, et al. Hepatitis C virus: evidence for sexual transmission. BMJ 1991; 302:1299-1302.
24. Riben P, Bailey G, Hudson S, McCulloch K, Dignan T, Martin D. Hepatitis C in Canada's First Nations, Inuit populations: an unknown burden. Can J Public Health 2000; 91(suppl 1):S16-S17.
25. MacDonald M, Crofts N, Kaldor J. Transmission of hepatitis C virus: rates, routes and co-factors. Epidemiol Rev 1996; 18:137-148.
26. Hwang LY, Ross MW, Zack C, Bull L, Rickman K, Holleman M. Prevalence of sexually transmitted infections and associated risk factors among populations of drug abusers. Clin Infect Dis 2000; 31:920-926.
27. Akahane Y, Kojima M, Sugai Y, et al. Hepatitis C virus infection in spouses of patients with type C chronic liver disease. Ann Intern Med 1994; 120:748-752.
28. Delage G, Infante-Rivard C, Chiavetta JA, Willems B, Pi D, Fast M. Risk factors for acquisition of hepatitis C virus infection in blood donors: results of a case-control study. Gastroenterology 1999; 116:893-899.